The period specified in part twelve of this Article may be extended up to six years, if, during the first three years after the state registration of a reference/original medicinal product, the central executive authority implementing the state policy in the field of healthcare shall authorise to use it for one or more indications that are considered to have a particular advantage over the existing ones. The rules and criteria for determining indications that have a particular advantage over existing ones shall be established by the central executive authority in charge of shaping the state policy in the field of healthcare. The period specified in part twelve of this Article shall be established if the application for state registration in Ukraine of the reference/original medicinal product is submitted within two years from the date of its first registration in any country.